Company: RGNT
Filing Date: 2025-09-30
Form Type: F-1/A
Source: 0001213900-25-093302
Chunk: 318

Company: REGENTIS BIOMATERIALS LTD.
Filing Date: 2025-09-30
Form: F-1/A
Chunk 318
---
ended and Restated Amendment to Settlement Agreement by and between Regentis Biomaterials Ltd. and Eli Hazum                            |
| 10.22* |     | Form of Amended and Restated Amendment to April 2025 Loan Agreement, by and among Regentis Biomaterials Ltd. and the lender parties thereto       |
| 23.1** |     | Consent of Brightman Almagor Zohar & Co., a Firm in the Deloitte Global Network, an independent registered public accounting firm                 |
| 23.2*  |     | Consent of Doron Tikotzky Kantor Gutman & Amit Gross (included in Exhibit 5.1)                                                                    |
| 23.3*  |     | Consent of Greenberg Traurig, LLP (included in Exhibit 5.2)                                                                                       |
| 24.1*  |     | Power of Attorney (included in signature pages of Registration Statement)                                                                         |
| 99.1*  |     | Consent of Dr. Susan Alpert as Director Nominee                                                                                                   |
| 99.2*  |     | Consent of Pini Ben-Elazar as Director Nominee                                                                                                    |
| 99.3*  |     | Consent of Efraim Cohen-Arazi as Director Nominee                                                                                                 |
| 107*   |     | Filing Fee Table                                                                                                                                  |

| *  | Previously filed.                                           |
| ** | Filed Herewith.                                             |
| +  | Indicates a management                                      
 contract or any compensatory plan, contract or arrangement. |

<div align='center'>II-8

SIGNATURES</div>

Pursuant to the requirements
of the Securities Act of 1933, as amended, the Registrant certifies that it has reasonable grounds to believe that it meets all of the
requirements for filing on Form F-1 and has duly caused this Registration Statement to be signed on its behalf by the undersigned,
thereunto duly authorized, in Herzliya, Israel on this 29 day of September, 2025.

| REGENTIS BIOMATERIALS LTD. |                         |
| By:                        | /s/ Dr. Eli             
 Hazum                   |
|                            | Dr. Eli Hazum,          |
|                            | Chief Executive Officer |

Pursuant to the requirements
of the Securities Act, this Registration Statement has been signed by the following persons in the capacities and on the dates indicated.

| Signature